NEW YORK, NY / ACCESSWIRE / February 12, 2018 / U.S. markets managed to finish in the green on Friday, despite concerns of rising interest rates and inflationary pressure. The Dow Jones Industrial Average jumped 1.38 percent to close at 24,190.90, while the S&P 500 Index increased 1.49 percent to close at 2,619.55. The Nasdaq Composite Index increased 1.44 percent to close at 6,874.49. The Cboe Volatility Index, a key measure of market expectations of near-term volatility, reached a high of 41.06 on Friday, before settling at 29.06.

According to Richard Hastings, a macro strategist at Seaport Global Securities LLC, "The bull market is not over. It is getting a new and better price, so it can go higher all over again. The relationship of the price?of many stocks?to their own yields and to interest rates, all went into chaos. Order is being restored."

RDI Initiates Coverage on:

Amgen Inc.
https://rdinvesting.com/news/?ticker=AMGN

Celgene Corporation
https://rdinvesting.com/news/?ticker=CELG

Amgen's stock edged 0.20% higher Friday, to close the day at $173.46. The stock recorded a trading volume of 6,093,941 shares, which was above its three months average volume of 3,222,703 shares. In the last year, Amgen's shares have traded in a range of 152.16 - 201.23. The stock is currently trading 13.80% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $183.36 is greater than its 200-day moving average of $178.71. Shares of the company are trading at a trailing Price to Earnings ratio of 64.48. Shares of Amgen have fallen roughly 4.67 percent in the past month and are down 0.25 percent year-to-date.

Access RDI's Amgen Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AMGN

On Friday, shares of Celgene recorded a trading volume of 11,150,259 shares, which was above the three months average volume of 7,057,080 shares. The stock ended the day 1.64% higher at 92.51. The stock is currently trading 37.14% below its 52-week high with a 52-week trading range of 88.32 - 147.17. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $102.48 is below its 200-day moving average of $118.85. Shares of the company are trading at a trailing Price to Earnings ratio of 25.41. Shares of Celgene have fallen roughly 11.54 percent in the past month and are down 11.35 percent year-to-date.

Access RDI's Celgene Corporation Research Report at:
https://rdinvesting.com/news/?ticker=CELG

Our Actionable Research on Amgen Inc. (NASDAQ:AMGN) and Celgene Corporation (NASDAQ:CELG) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com